Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison

Peter Nash, Iain B. McInnes, Philip J. Mease, Howard Thom, Matthias Hunger, Andreas Karabis, Kunal Gandhi, Shephard Mpofu & • Steffen M. Jugl
Article full text
The full text of this article can be found here. https://link.springer.com/article/10.1007/s40744-018-0106-6
Provide enhanced content for this article
If you are an author of this publication and would like to provide additional enhanced content for your article then please contact adisrapidplus@springer.com.
The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the...
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.